Characteristics of patients with fibromyalgia in France and Germany

International Journal of Clinical Practice

Volumn 64, Issue 8, 2010, Pages 1100-1108

  Perrot, S ^a   Winkelmann, A ^b   Dukes, E ^c   Xu, X ^d   Schaefer, C ^d   Ryan, K ^d   Chandran, A ^d   Sadosky, A ^d   Zlateva, G ^d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Pfizer Global Health Economics   (United States)

^d Covance Market Access Services Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADULT; AGED; ANXIETY DISORDER; ARTICLE; BRIEF PAIN INVENTORY; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; EMPLOYMENT STATUS; FEMALE; FIBROMYALGIA; FRANCE; GERMANY; HEALTH STATUS; HEALTH SURVEY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; SLEEP DISORDER;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; COST OF ILLNESS; EFFICIENCY; EMPLOYMENT; FEMALE; FIBROMYALGIA; FRANCE; GERMANY; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PAIN; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; SLEEP DISORDERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77953827351     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02418.x     Document Type: Article

References (39)

1. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995 38 : 19 28.
2. Arnold LM, Hudson JI, Keck PE Jr., Auchenback MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 2006 67 : 1219 1225.
3. Bigatti SM, Hernandez AM, Cronan TA, Rand KL. Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Rheum 2008 59 : 961 967.
4. White LA, Birnbaum HG, Kaltenboeck A, Tang J, Mallett D, Robinson RL. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med 2008 50 : 13 24.
5. Nazonov EL, Soldatov D, Le Lay K, Boussetta S, Caubére J, Taïeb C. Prevalence of fibromyalgia: a large-scale European survey: results in Russia. Poster, presented at EULAR 2008 June 11-14, Paris, France.
6. Späth M, Le Lay K, Boussetta S, André E, Caubère JP, Taïeb C. Prevalence of Fibromyalgia: a large-scale European survey: results in Germany. Poster, presented at EULAR 2008 June 11-14, Paris, France.
7. Bannwarth B, Blotman F, Rouè-Le Lay K, Caubère JP, Andrè E, Taïeb C. Fibromyalgia syndrome in the general population of France: a prevalence study. Joint Bone Spine 2009 76 : 184 187.
8. Kollner V, Bernardy K, Sommer C, Häuser W. Diagnosis and therapy of fibromyalgia syndrome. Dtsch Med Wochenschr 2009 134 : 1163 1174.
9. Pillemer SR, Bradley LA, Crofford LJ, Moldofsky H, Chrousos GP. The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 1997 40 : 1928 1939.
10. Bennett RM. Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc 1999 74 : 385 389.
11. Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol 2003 17 : 658 701.
12. Harrison S, Geppetti P. Substance p. Int J Biochem Cell Biol 2001 33 : 555 576.
13. Datar P, Srivastava S, Coutinho E, Govil G. Substance p: structure, function, and therapeutics. Curr Top Med Chem 2004 4 : 75 103.
14. McVeigh JG, Hurley DA, Basford JR, Sim J, Finch MB. The pathogenesis of fibromyalgia syndrome: an update. Phys Ther Rev 2003 8 : 211 216.
15. Ablin J, Neumann L, Buskila D. Pathogenesis of fibromyalgia - a review. Joint Bone Spine 2008 75 : 273 279.
16. Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990 33 : 160.
17. American Pain Society. Guideline for the management of fibromyalgia syndrome pain in adults and children. APS Clinical Practice Guidelines Series, No. 4.
18. Carville SF, Arendt-Nielsen S, Bliddal H et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008 67 : 536 541.
19. Häuser W, Arnold B, Eich W et al. Management of fibromyalgia syndrome - an interdisciplinary evidence-based guideline. Ger Med Sci 2008 6 : 1 11.
20. Eich W, Häuser W, Friedel E et al. Definition, classification, and diagnosis of fibromyalgia syndrome. Smerz 2008 22 : 255 266.
21. Häuser W, Akritidou I, Felde E et al. Steps toward a symptom-based diagnosis of fibromyalgia syndrome. Symptom profiles from patients from different clinical settings. Z Rheumatol 2008 67 : 511 515.
22. Mease PJ, Clauw DJ, Arnold LM et al. Fibromyalgia syndrome. J Rheumatol 2005 32 : 2270 2277.
23. Boonen A, van den Heuvel R, van Tubergen A et al. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Ann Rheum Dis 2005 64 : 396 402.
24. Hughes G, Martinez C, Myon E, Taïeb C, Wessely S. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 2006 54 : 177 183.
25. Berger A, Sadosky A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany. Curr Med Res Opin 2008 24 : 2489 2499.
26. Bennett RM. The rational management of fibromyalgia patients. Rheum Dis Clin North Am 2002 28 : 181 199.
27. Rao SG, Bennett RM. Pharmacological therapies in fibromyalgia. Best Pract Res Clin Rheuamtol 2003 17 : 611 627.
28. Picavet HSJ, Hoeymans N. Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study. Ann Rheum Dis 2004 63 : 723 729.
29. Cöster L, Kendall S, Gerdle B, Henriksson C, Henriksson KG, Bengtsson A. Chronic widespread musculoskeletal pain - a comparison of those who meet criteria for fibromyalgia and those who do not. Eur J Pain 2008 12 : 600 610.
30. Sinclair JD, Starz TW, Turk DC. The Manual Tender Point Survey.
31. EuroQol Group. EuroQol: a new facility for the measurement of health related quality of life. Health Policy 1990 16 : 199 208.
32. Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991 18 : 728 734.
33. Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky A. Clinically important percentage change in the fibromyalgia impact questionnaire. J Rheumatol 2009 36 : 5.
34. Zelman D, Dukes E, Brandenburg N, Bostrom A, Gore M. Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy. Pain 2005 115 : 29 36.
35. Hays RD, Stewart AL (1992) Sleep measures. In : Stewart AL, Ware JE, eds. Measuring Functioning and Well-Being: The Medical Outcomes Study Approach.
36. Zigmond A, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983 67 : 361 370.
37. Carpenter JS, Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 1998 45 : 5 13.
38. Cappelleri JC, Bushmakin AG, McDermott AM et al. Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibromyalgia. Sleep Med 2009 10 : 766 770. Epub. 29 January 2009.
39. Ubago Linares Mdel C, Ruiz-Perez I, Bermejo Perez MJ, Olry de Labry-Lima A, Hernandez-Torres E, Plazaola-Castano J. Analysis of the impact of fibromyalgia on quality of life: associated factors. J Clin Rheumatol 2008 27 : 613 619.